Jari Tiihonen

Jari Tiihonen is a Professor of Clinical Psychiatry at Karolinska Institutet since 2011, affiliated with the Department of Clinical Neuroscience. He leads the Real-world effectiveness of psychopharmacological treatment – Jari Tiihonen's Research Group, focusing on registry-based studies of psychiatric medications' real-world outcomes. His work emphasizes schizophrenia, bipolar disorder, and depression treatment efficacy, with a focus on mortality, relapse prevention, and adherence.

• Education: Docent degree from the University of Kuopio (1992).
• Research: Explores antipsychotic efficacy, clozapine augmentation, and pharmacotherapy in forensic and general psychiatric populations. Key areas include:
• Neurobiological mechanisms of psychopathy and schizophrenia.
• Long-term safety and outcomes of antipsychotics.
• Effects of medications on mortality and labor market outcomes.
• Publications: Over 500 peer-reviewed articles (2025 highlights include studies on clozapine efficacy, forensic psychiatry, and AI-driven mortality risk prediction).
• Labs/Teams: Directs a multidisciplinary group analyzing large-scale health registries to inform clinical practice.